Automated analysis of co-localized protein expression in histologic sections of prostate cancer.

by Thomas A Tennill, Mitchell E Gross, Hermann B Frieboes
Published 2017-01-01

Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)

by Katherin Patsch, Naim Matasci, Anjana Soundararajan, Patricia Diaz, David B. Agus, Daniel Ruderman, Mitchell E. Gross
Published 2019-05-01

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

by Jacqueline K. Dawson, Tanya B. Dorff, E. Todd Schroeder, Christianne J. Lane, Mitchell E. Gross, Christina M. Dieli-Conwright
Published 2018-04-01

Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.

by Angel E Dago, Asya Stepansky, Anders Carlsson, Madelyn Luttgen, Jude Kendall, Timour Baslan, Anand Kolatkar, Michael Wigler, Kelly Bethel, Mitchell E Gross, James Hicks, Peter Kuhn
Published 2014-01-01

Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.

by Nitin Patel, Tatsuo Itakura, Shinwu Jeong, Chun-Peng Liao, Pradip Roy-Burman, Ebrahim Zandi, Susan Groshen, Jacek Pinski, Gerhard A Coetzee, Mitchell E Gross, M Elizabeth Fini
Published 2015-01-01

Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial

by Jacqueline K. Dawson PhD, Tanya B. Dorff MD, Creighton Tuzon PhD, Judd C. Rice PhD, Edward Todd Schroeder PhD, Christianne J. Lane PhD, Mitchell E. Gross MD, PhD, Christina M. Dieli-Conwright PhD
Published 2021-07-01